Skip to main content

Table 3 Descriptive and comparative analyses between the four drugs studied regarding the number of intravitreal injections after the loading dose

From: Comparison of antiangiogenic agents (ranibizumab, aflibercept, bevacizumab and ziv-aflibercept) in the therapeutic response to the exudative form of age-related macular degeneration according to the treat-and-extend protocol- true head-to-head study

Drug

n

 

P

  

Mean ± SD

 

Aflibercept (1)

33

9.03 ± 0.17

 < 0.001

(F3. 127 = 12.267)

1 < (2 = 4 = 3)

Bevacizumab (2)

32

10.06 ± 1.13

Ranibizumab (3)

33

10.52 ± 1.33

Ziv-aflibercept (4)

33

10.06 ± 1.09

General

131

9.92 ± 1.16

 
  1. Notes: Welch’s test
Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us